It is only undervalued because, as previously commented on, the company is viewed as a company that focuses on developing innovative 'cannabinoid-based pharmaceuticals and dermatology products'. Also, it is still in the speccy area of the share market.
As we (the shareholders) all know by now, this is going to radically change in the near future. To be honest, I can't even predict how many bags we will make from this baby!
BOT - Anything but charting, page-7381
-
- There are more pages in this discussion • 1,883 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.055(16.9%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 38.0¢ | 33.0¢ | $7.103M | 19.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 134000 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 650314 | 19 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |